Før et aktivstof godkendes, bør medlemsstaterne, de berørte parter og i givet fald Kommissionen have en rimelig frist til at forberede sig, så de kan opfylde de nye krav, godkendelsen medfører.
A reasonable period should be allowed to elapse before an active substance is approved, in order to permit Member States, interested parties, and the Commission where appropriate, to prepare themselves to meet the new requirements entailed.